• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. RUBY COIL LP; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. RUBY COIL LP; HCG, KRD Back to Search Results
Catalog Number RBYLP0204
Medical Device Problem Codes Break (1069); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/19/2022
Type of Reportable Event Malfunction
Event or Problem Description
The patient was undergoing a radioembolization procedure (y90) in the liver using ruby coil lps and a non-penumbra microcatheter.During the procedure, the ruby coil lp would not advance out of its introducer sheath.Therefore, the ruby coil lp was removed.While attempting to use another ruby coil lp, the physician had difficulty advancing the ruby coil lp out of its introducer sheath.Subsequently, while advancing the same ruby coil lp through the microcatheter, the physician and the hospital technologist experienced resistance and the ruby coil lp partially broke in the microcatheter.Therefore, the physician used a hemostat and a syringe and removed the broken ruby coil lp.It was reported that a part of the coil was attached to the pusher assembly.The procedure was completed using non-penumbra coils and the same microcatheter.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Additional Manufacturer Narrative
Please note that the device associated with this complaint was expected to be returned; however, additional information received from the penumbra sales representative indicated that the device was disposed of and is no longer available for return.Therefore, without the return of the device, the root cause of the problem cannot be determined.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBY COIL LP
Common Device Name
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key15414486
Report Number3005168196-2022-00428
Device Sequence Number14866008
Product Code HCG
UDI-Device Identifier00815948021754
UDI-Public815948021754
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K192955
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/28/2022
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberRBYLP0204
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/19/2022
Supplement Date Received by Manufacturer10/12/2022
Initial Report FDA Received Date09/13/2022
Supplement Report FDA Received Date10/29/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age65 YR
Patient SexFemale
Date Report Sent to FDA01/01/2005
-
-